The $5 million term-debt facility will provide growth capital to support Epica's expansion into new markets across both imaging and robotics, according to the New York City-based firm. The funds will be used for expanding the firm's operations, increasing its sales force, and preparing for entry into the medical market, Epica CEO Frank D'Amelio said in a statement.
Epica said it has five subsidiaries: a CT imaging company, a robotics company, an R&D technology center, a medical products distribution company, and a technical and scientific distribution group. The firm's goal is to integrate CT imaging with precision robotics.
Copyright © 2017 AuntMinnie.com